Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

With the potential development of new disease-modifying Alzheimer’s Disease (AD) therapies, simple, widely available screening tests are needed to identify which individuals who are experiencing symptoms of cognitive or behavioral decline should be further evaluated for initiation of treatment. A bl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nat Med
Autori principali: Thijssen, Elisabeth H., La Joie, Renaud, Wolf, Amy, Strom, Amelia, Wang, Ping, Iaccarino, Leonardo, Bourakova, Viktoriya, Cobigo, Yann, Heuer, Hilary, Spina, Salvatore, VandeVrede, Lawren, Chai, Xiyun, Proctor, Nicholas K., Airey, David C., Shcherbinin, Sergey, Evans, Cynthia Duggan, Sims, John R., Zetterberg, Henrik, Blennow, Kaj, Karydas, Anna M., Teunissen, Charlotte E., Kramer, Joel H., Grinberg, Lea T., Seeley, William W., Rosen, Howie, Boeve, Bradley F., Miller, Bruce L., Rabinovici, Gil D., Dage, Jeffrey L., Rojas, Julio C., Boxer, Adam L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7101073/
https://ncbi.nlm.nih.gov/pubmed/32123386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-020-0762-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi